Streptococcus sanguis American Type Culture Collection (ATCC) strain 10557 showed atypical reactions in dextran formation, streptocin activity, and response to mitomycin C when compared with other S. sanguis strains. Therefore, ATCC 10557 must be considered an aberrant member of S. sanguis; alternatively, this strain should not be assigned t o this species.
In 1946, White and Niven (12) isolated a group of a-hemolytic streptococci from the blood of endocarditis patients. These isolates, originally called Streptococcus s.b.e., were regarded as belonging t o a new species, which White (1 2) named Streptococcus sanguis. The ability of a microorganism t o cause endocarditis does not, however, mean that the microbe is a member of the species S. sanguis. since other organisms can cause this disease. Important physiological characteristics of this species included (Y hemolysis on blood agar, dextran production from 5% sucrose broth, ammonia production from arginine, fermentation of inulin, and failure t o ferment mannitol, sorbitol, or raffinose. However, White and Niven (1 2) observed certain strains showing atypical reactions in several of these characteristics.
Interest in S. sanguis has continued, due t o its implication in endocarditis and t o its predominance in human dental plaque (3), and the number of isolates of this organism has increased substantially. With this increase, the diversity within S. sanguis became more apparent. For example, certain strains can grow on chemically defined media whereas others cannot (4). s. sanguis ATCC 10557 (9) is related serologically t o S. salivarius HHT (1 1) and resembles it on mitis-salivarius agar (I. L. Shklair, personal communication). In recent work, we have observed that American Type Culture Collection (ATCC) strain 105 57 differs from ATCC 10556, 10558, and other strains of S sanguis in three additional properties.
The bacterial strains studied included S.
sanguis ATCC 10556, 10557, 10558, S. sanguis F90A, S. sanguis enole, S. sanguis challis, and other strains of S. sanguis as well as S. mutans K l R and S. mutans GS5. These strains were obtained from the Dental Sciences Department, Naval Medical Research Institute, Bethesda, Md., and from the Center for Disease Control, Atlanta, Ga. The media used included brain heart infusion broth supplemented with 2% yeast extract (BHIYE), BHIYE plus 1.5% agar, sucrose broth (S), and P broth (8) . Difco products were used.
Biochemical activity. Three characteristics of S. sanguis which distinguish it from S. mutans are: gelling of 5% sucrose broth and the inability t o ferment mannitol or sorbitol (J. D.
DeSt oppelaar, Ph. D. thesis, Rijksuniversi teit , Utrecht, 1971) . ATCC 10557 behaves like neither S. sanguis nor S. mutans (Table 1) .
Antimicrobial inhibition. One interesting characteristic of S. sanguis is its ability to inhibit, at least in vitro, the growth of a wide spectrum of streptococci (6) . While developing a strain-typing system for S. sanguis based on inhibition (E. Crooks, R. Kolstad, and J. Cole, J. Dent. Res., Abstr. 281, 1973), we observed that ATCC 10557 does not share this antimicrobial activity ( Table 2) .
Insensitivity to mitomycin C. The in vitro inhibition of gram-positive bacteria by S. sanguis has been linked t o streptocins (2, 7). Because bacteriocin induction leads t o the death of the activated cell ( l o ) , we examined the ability of mitomycin C, an effective inducing agent of some bacteriocins (1 ) exposed to 0.1 p u g of mitomycin C in P broth (10) for 2 h, is relatively insensitive t o the drug, whereas five representative strains of S. sanguis are sensitive (Table 3) .
In conclusion, ATCC 10557, originally assigned to the species s. sanguis by White and Niven (12) because it was isolated from the blood of an endocarditis patient, differs in several properties from representative members of the species. ATCC 10557 must be considered an aberrant member of S. sanguis ; alternatively,
